Aytu BioPharma Reports Q1 Earnings Beat on Revenue and EPS

Aytu BioPharma (AYTU) reported first-quarter financial results that exceeded analyst expectations for both earnings per share and revenue. The company posted a GAAP EPS of -$0.20, which outperformed estimates by $0.14. Total revenue for the quarter reached $14.84 million, representing a 6.8% increase year-over-year. This figure surpassed consensus estimates by approximately $1.57 million, signaling stronger top-line growth than previously anticipated by the market.

By https://seekingalpha.com/user/61083391/bio · Seeking Alpha ·

Aytu BioPharma Reports Q1 Earnings Beat on Revenue and EPS

Topics: earnings beat GAAP EPS revenue growth

Read the full article at Seeking Alpha

More World news